
Baxter BioPharma Solutions
Advertisement
Articles by Baxter BioPharma Solutions


Your oncology product can make a difference in patients’ lives, and our oncology manufacturing expertise can help you make that difference.


- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation

This case study looks at considerations for formulations of Mannitol, a versatile excipient used in freeze-dried injectables in the pharmaceutical industry.
Advertisement
Latest Updated Articles
Complex Sterile Manufacturing of Oncology ProductsPublished: October 20th 2020 | Updated:
Hemihydrate Formation: Considerations for Mannitol FormulationsPublished: February 24th 2020 | Updated:
Oncology Product Manufacturing in a Non-Dedicated FacilityPublished: March 19th 2020 | Updated:
Oncology Product Manufacturing in a Nondedicated FacilityPublished: March 19th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
5
